Skip to main content

FIRST BUSEY CORP /NV/ (BUSE) Stock Forecast 2025 - AI Price Prediction & Analysis


FIRST BUSEY CORP /NV/ (BUSE) AI Stock Price Forecast & Investment Analysis

FIRST BUSEY CORP /NV/ Stock Price Chart and Technical Analysis

Loading FIRST BUSEY CORP /NV/ interactive price chart and technical analysis...

FIRST BUSEY CORP /NV/ (BUSE) - Comprehensive Stock Analysis & Investment Research

Deep dive into FIRST BUSEY CORP /NV/'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about FIRST BUSEY CORP /NV/, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For FIRST BUSEY CORP /NV/: FIRST BUSEY CORP /NV/ operates in the Finance sector, establishing it as a mid-cap growth opportunity.

FIRST BUSEY CORP /NV/ (Stock Symbol: BUSE) is a leading company in the Finance sector , specifically operating within the State Commercial Banks industry.

The organization employs approximately 1311 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing FIRST BUSEY CORP /NV/'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For FIRST BUSEY CORP /NV/: With $413M in annual revenue and 27.6% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $413 million generating a 27.6% net profit margin .

Market Capitalization: $2067 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): 9.2% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for FIRST BUSEY CORP /NV/ stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For FIRST BUSEY CORP /NV/: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for FIRST BUSEY CORP /NV/ stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: FIRST BUSEY CORP /NV/'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For FIRST BUSEY CORP /NV/: Strong free cash flow generation demonstrates solid operational efficiency.

FIRST BUSEY CORP /NV/ strategically competes in the highly dynamic State Commercial Banks marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company demonstrates robust operational efficiency through strong free cash flow generation of $157 million annually, complemented by impressive 109.5% year-over-year cash flow growth.

FIRST BUSEY CORP /NV/ (BUSE) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for FIRST BUSEY CORP /NV/ stock analysis.

Loading FIRST BUSEY CORP /NV/ comprehensive fundamental analysis and insider trading data...

Deep dive into FIRST BUSEY CORP /NV/'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if FIRST BUSEY CORP /NV/ stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For FIRST BUSEY CORP /NV/: With a P/E ratio of 13.33, the market sees the stock as potentially undervalued.

P/E Ratio 13.33x
P/B Ratio 0.86x
Market Cap $2067M
Dividend Yield 0.01%
EPS $2.02
Book Value/Share $27.07
Revenue/Share $7.38
FCF/Share $2.26
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently FIRST BUSEY CORP /NV/ converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For FIRST BUSEY CORP /NV/: An ROE of 9.2% indicates room for improvement in shareholder value creation.

ROE 9.2%
ROA 1.0%
Net Margin 27.6%
EBT Margin 34.8%
Tax Rate 20.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess FIRST BUSEY CORP /NV/'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For FIRST BUSEY CORP /NV/:

D/E Ratio 0.28x
Financial Leverage 10.32x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal FIRST BUSEY CORP /NV/'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For FIRST BUSEY CORP /NV/: Free cash flow of $157M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $160M
Free Cash Flow $157M
Capital Spending $-4M
OCF Growth YoY 109.5%
FCF Growth YoY 144.4%
FCF/Sales 37.9%
CapEx/Sales 0.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively FIRST BUSEY CORP /NV/ uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For FIRST BUSEY CORP /NV/: An asset turnover of 0.04x suggests room for improvement in asset utilization.

Asset Turnover 0.04x
Fixed Assets Turnover 2.9x
Understanding Financial Statement Data

What these metrics mean: Key figures from FIRST BUSEY CORP /NV/'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For FIRST BUSEY CORP /NV/: With annual revenue of $413M, FIRST BUSEY CORP /NV/ demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $413M
SG&A Expense $43M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 27%
Total Liabilities 90%
Short-term Debt 0%
Dividend & Shareholder Information
Dividends Per Share $0.24
Payout Ratio 0.1%
Shares Outstanding 89M
Growth Metrics (YoY)
EPS Growth 7.5%

Latest FIRST BUSEY CORP /NV/ Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting FIRST BUSEY CORP /NV/ (BUSE) stock price and investment outlook.

📰 We are currently updating our news feed for FIRST BUSEY CORP /NV/. Check back soon for the latest market analysis and company updates.

FIRST BUSEY CORP /NV/ Competitors & Peer Analysis - Finance Sector

Comparative analysis of FIRST BUSEY CORP /NV/ against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABCB Unlock Forecast - 30 Days FREE Trial $5128M 13.0x 1.3x
ACNB Unlock Forecast - 30 Days FREE Trial $465M 18.9x 1.2x
AMAL Unlock Forecast - 30 Days FREE Trial $848M 8.3x 1.2x
ASB Unlock Forecast - 30 Days FREE Trial $4206M 30.5x 0.9x
ASBA Unlock Forecast - 30 Days FREE Trial $4083M 29.3x 0.9x
ASB-PE Unlock Forecast - 30 Days FREE Trial $3566M 25.6x 0.8x
ASB-PF Unlock Forecast - 30 Days FREE Trial $3515M 25.2x 0.7x
AUB Unlock Forecast - 30 Days FREE Trial $4784M 23.8x 1.0x
AUB-PA Unlock Forecast - 30 Days FREE Trial $3481M 17.1x 0.7x
BAFN Unlock Forecast - 30 Days FREE Trial $39M 4.2x 0.4x
BANR Unlock Forecast - 30 Days FREE Trial $2170M 12.1x 1.2x
BCML Unlock Forecast - 30 Days FREE Trial $301M 12.6x 0.9x
BFST Unlock Forecast - 30 Days FREE Trial $716M 9.6x 0.8x
BHB Unlock Forecast - 30 Days FREE Trial $461M 12.0x 1.0x
BK Unlock Forecast - 30 Days FREE Trial $77869M 15.5x 1.8x
BK-PK Unlock Forecast - 30 Days FREE Trial $18771M 3.8x 0.4x
BKSC Unlock Forecast - 30 Days FREE Trial $88M 13.5x 2.1x
BMRC Unlock Forecast - 30 Days FREE Trial $419M 57.1x 1.0x
BOH Unlock Forecast - 30 Days FREE Trial $2549M 14.9x 1.4x
BOH-PA Unlock Forecast - 30 Days FREE Trial $671M 3.9x 0.4x
BOH-PB Unlock Forecast - 30 Days FREE Trial $1027M 6.0x 0.6x
BOTJ Unlock Forecast - 30 Days FREE Trial $72M 10.0x 1.0x
BPOP Unlock Forecast - 30 Days FREE Trial $7645M 10.7x 1.3x
BPOPM Unlock Forecast - 30 Days FREE Trial $1709M 2.4x 0.3x
BPOPO Unlock Forecast - 30 Days FREE Trial $1702M 2.4x 0.3x
BPRN Unlock Forecast - 30 Days FREE Trial $210M 30.7x 0.8x
BSRR Unlock Forecast - 30 Days FREE Trial $392M 9.2x 1.1x
BSVN Unlock Forecast - 30 Days FREE Trial $401M 9.2x 1.7x
BUSE Unlock Forecast - 30 Days FREE Trial $2067M 13.3x 0.9x
BWB Unlock Forecast - 30 Days FREE Trial $461M 12.6x 1.0x
BWBBP Unlock Forecast - 30 Days FREE Trial $536M 14.1x 1.1x
BWFG Unlock Forecast - 30 Days FREE Trial $346M 16.8x 1.2x
BY Unlock Forecast - 30 Days FREE Trial $1255M 10.9x 1.1x
CATY Unlock Forecast - 30 Days FREE Trial $3243M 11.1x 1.1x
CBAN Unlock Forecast - 30 Days FREE Trial $285M 10.5x 1.0x
CBFV Unlock Forecast - 30 Days FREE Trial $167M 14.4x 1.1x
CBSH Unlock Forecast - 30 Days FREE Trial $6649M 13.7x 2.7x
CCB Unlock Forecast - 30 Days FREE Trial $1611M 34.5x 3.5x
CCBG Unlock Forecast - 30 Days FREE Trial $695M 12.2x 1.3x
CCFN Unlock Forecast - 30 Days FREE Trial $186M 9.1x 1.1x
CCNE Unlock Forecast - 30 Days FREE Trial $510M 9.5x 0.8x
CCNEP Unlock Forecast - 30 Days FREE Trial $524M 9.6x 0.8x
CFFI Unlock Forecast - 30 Days FREE Trial $223M 9.0x 0.9x
CFG Unlock Forecast - 30 Days FREE Trial $22465M 13.9x 0.9x
CFG-PE Unlock Forecast - 30 Days FREE Trial $8745M 5.5x 0.4x
CFG-PH Unlock Forecast - 30 Days FREE Trial $11343M 7.1x 0.5x
CHMG Unlock Forecast - 30 Days FREE Trial $248M 22.7x 1.1x
CIVB Unlock Forecast - 30 Days FREE Trial $338M 10.8x 0.9x
CNOB Unlock Forecast - 30 Days FREE Trial $1209M 33.0x 0.8x
CNOBP Unlock Forecast - 30 Days FREE Trial $1212M 32.3x 0.8x
COFS Unlock Forecast - 30 Days FREE Trial $453M 29.4x 1.1x
COLB Unlock Forecast - 30 Days FREE Trial $5402M 10.2x 1.0x
COSO Unlock Forecast - 30 Days FREE Trial $226M x 1.1x
CPF Unlock Forecast - 30 Days FREE Trial $801M 13.1x 1.4x
CSBB Unlock Forecast - 30 Days FREE Trial $135M 10.5x 1.1x
CTBI Unlock Forecast - 30 Days FREE Trial $949M 10.5x 1.2x
CUBB Unlock Forecast - 30 Days FREE Trial $657M 4.5x 0.4x
CUBI Unlock Forecast - 30 Days FREE Trial $2178M 15.0x 1.2x
CUBI-PF Unlock Forecast - 30 Days FREE Trial $800M 5.4x 0.4x
CVBF Unlock Forecast - 30 Days FREE Trial $2613M 12.9x 1.2x
CWBC Unlock Forecast - 30 Days FREE Trial $410M 15.5x 1.1x
CZFS Unlock Forecast - 30 Days FREE Trial $261M 8.5x 0.8x
CZNC Unlock Forecast - 30 Days FREE Trial $304M 11.2x 1.1x
EBMT Unlock Forecast - 30 Days FREE Trial $134M 10.6x 0.7x
EFSC Unlock Forecast - 30 Days FREE Trial $2029M 10.1x 1.1x
EFSCP Unlock Forecast - 30 Days FREE Trial $740M 3.7x 0.4x
EFSI Unlock Forecast - 30 Days FREE Trial $201M 25.4x 1.1x
EGBN Unlock Forecast - 30 Days FREE Trial $541M -22.5x 0.5x
EMYB Unlock Forecast - 30 Days FREE Trial $132M 11.2x 1.2x
EQBK Unlock Forecast - 30 Days FREE Trial $731M 11.0x 1.2x
EWBC Unlock Forecast - 30 Days FREE Trial $14291M 11.9x 1.7x
FBIZ Unlock Forecast - 30 Days FREE Trial $417M 8.9x 1.2x
FBK Unlock Forecast - 30 Days FREE Trial $2548M 28.3x 1.6x
FBNC Unlock Forecast - 30 Days FREE Trial $2061M 20.6x 1.3x
FBP Unlock Forecast - 30 Days FREE Trial $3199M 10.7x 1.7x
FCBC Unlock Forecast - 30 Days FREE Trial $608M 12.3x 1.2x
FCCO Unlock Forecast - 30 Days FREE Trial $211M 12.2x 1.4x
FCNCA Unlock Forecast - 30 Days FREE Trial $23943M 9.8x 1.1x
FCNCB Unlock Forecast - 30 Days FREE Trial $20242M 8.5x 0.9x
FCNCO Unlock Forecast - 30 Days FREE Trial $302M 0.1x 0.0x
FCNCP Unlock Forecast - 30 Days FREE Trial $298M 0.1x 0.0x
FFIC Unlock Forecast - 30 Days FREE Trial $443M 19.5x 0.6x
FFIN Unlock Forecast - 30 Days FREE Trial $4489M 18.2x 2.6x
FFWM Unlock Forecast - 30 Days FREE Trial $453M -23.9x 0.4x
FHB Unlock Forecast - 30 Days FREE Trial $3118M 12.5x 1.2x
FIBK Unlock Forecast - 30 Days FREE Trial $3374M 14.5x 1.0x
FINW Unlock Forecast - 30 Days FREE Trial $239M 18.0x 1.3x
FITB Unlock Forecast - 30 Days FREE Trial $27303M 11.7x 1.3x
FITBI Unlock Forecast - 30 Days FREE Trial $17140M 7.3x 0.8x
FITBO Unlock Forecast - 30 Days FREE Trial $13595M 5.8x 0.6x
FITBP Unlock Forecast - 30 Days FREE Trial $16559M 7.1x 0.8x
FKYS Unlock Forecast - 30 Days FREE Trial $104M 13.4x 1.0x
FMBH Unlock Forecast - 30 Days FREE Trial $881M 10.6x 1.0x
FMBM Unlock Forecast - 30 Days FREE Trial $97M 11.4x 1.0x
FMNB Unlock Forecast - 30 Days FREE Trial $506M 10.0x 1.2x
FRAF Unlock Forecast - 30 Days FREE Trial $196M 13.5x 1.2x
FSBC Unlock Forecast - 30 Days FREE Trial $787M 14.7x 1.9x
FUSB Unlock Forecast - 30 Days FREE Trial $71M 12.2x 0.9x
FVCB Unlock Forecast - 30 Days FREE Trial $225M 11.3x 0.9x
FXNC Unlock Forecast - 30 Days FREE Trial $206M 25.9x 1.2x
GABC Unlock Forecast - 30 Days FREE Trial $1469M 17.1x 1.4x
GBCI Unlock Forecast - 30 Days FREE Trial $5168M 23.5x 1.5x
GBFH Unlock Forecast - 30 Days FREE Trial $553M 60.7x 3.7x
GSBC Unlock Forecast - 30 Days FREE Trial $654M 9.7x 1.1x
HBIA Unlock Forecast - 30 Days FREE Trial $694M 12.3x 1.4x
HBNC Unlock Forecast - 30 Days FREE Trial $720M 13.5x 0.9x
HBT Unlock Forecast - 30 Days FREE Trial $776M 10.3x 1.3x
HNVR Unlock Forecast - 30 Days FREE Trial $152M 13.3x 0.8x
HOMB Unlock Forecast - 30 Days FREE Trial $5394M 15.8x 1.3x
HONE Unlock Forecast - 30 Days FREE Trial $547M 21.7x 0.9x
HTBK Unlock Forecast - 30 Days FREE Trial $651M 15.6x 0.9x
HTH Unlock Forecast - 30 Days FREE Trial $2018M 13.0x 0.9x
HWC Unlock Forecast - 30 Days FREE Trial $4822M 13.1x 1.1x
HWCPZ Unlock Forecast - 30 Days FREE Trial $2076M 5.5x 0.5x
IBCP Unlock Forecast - 30 Days FREE Trial $650M 10.3x 1.4x
IBOC Unlock Forecast - 30 Days FREE Trial $4232M 10.2x 1.4x
INBK Unlock Forecast - 30 Days FREE Trial $174M 11.3x 0.5x
INBKZ Unlock Forecast - 30 Days FREE Trial $215M 13.9x 0.6x
INDB Unlock Forecast - 30 Days FREE Trial $2911M 15.6x 1.0x
ISBA Unlock Forecast - 30 Days FREE Trial $264M 16.3x 1.2x
ISTR Unlock Forecast - 30 Days FREE Trial $241M 10.9x 0.9x
JMSB Unlock Forecast - 30 Days FREE Trial $273M 14.5x 1.1x
LKFN Unlock Forecast - 30 Days FREE Trial $1496M 16.9x 2.1x
LNKB Unlock Forecast - 30 Days FREE Trial $262M 7.0x 0.9x
LOB Unlock Forecast - 30 Days FREE Trial $1508M 27.9x 1.4x
MBCN Unlock Forecast - 30 Days FREE Trial $275M 15.2x 1.3x
MBIN Unlock Forecast - 30 Days FREE Trial $1487M 6.0x 0.7x
MBINL Unlock Forecast - 30 Days FREE Trial $1072M 4.2x 0.5x
MBINM Unlock Forecast - 30 Days FREE Trial $1109M 4.4x 0.5x
MBINN Unlock Forecast - 30 Days FREE Trial $949M 3.8x 0.4x
MBWM Unlock Forecast - 30 Days FREE Trial $726M 9.1x 1.2x
MCB Unlock Forecast - 30 Days FREE Trial $716M 10.7x 1.0x
MCBS Unlock Forecast - 30 Days FREE Trial $675M 10.2x 1.6x
MNSB Unlock Forecast - 30 Days FREE Trial $149M 11.1x 0.7x
MNSBP Unlock Forecast - 30 Days FREE Trial $190M 13.3x 0.9x
MOFG Unlock Forecast - 30 Days FREE Trial $789M -84.8x 1.3x
MPB Unlock Forecast - 30 Days FREE Trial $682M 15.3x 0.9x
MSBI Unlock Forecast - 30 Days FREE Trial $355M 7.4x 0.6x
MTB Unlock Forecast - 30 Days FREE Trial $29359M 11.1x 1.0x
MTB-PH Unlock Forecast - 30 Days FREE Trial $4042M 1.5x 0.1x
MTB-PJ Unlock Forecast - 30 Days FREE Trial $4318M 1.6x 0.2x
MVBF Unlock Forecast - 30 Days FREE Trial $344M 19.9x 1.1x
MYFW Unlock Forecast - 30 Days FREE Trial $217M 18.7x 0.8x
NPB Unlock Forecast - 30 Days FREE Trial $569M 15.3x 0.9x
NTRS Unlock Forecast - 30 Days FREE Trial $24134M 14.0x 1.9x
NTRSO Unlock Forecast - 30 Days FREE Trial $3825M 2.2x 0.3x
NWFL Unlock Forecast - 30 Days FREE Trial $246M 77.6x 1.1x
NWPP Unlock Forecast - 30 Days FREE Trial $76M 8.2x 1.0x
OBK Unlock Forecast - 30 Days FREE Trial $1086M 15.0x 0.9x
OBT Unlock Forecast - 30 Days FREE Trial $323M 11.2x 1.3x
OFG Unlock Forecast - 30 Days FREE Trial $1748M 9.1x 1.3x
OPBK Unlock Forecast - 30 Days FREE Trial $203M 9.1x 1.0x
ORRF Unlock Forecast - 30 Days FREE Trial $667M 15.6x 1.2x
OSBC Unlock Forecast - 30 Days FREE Trial $836M 10.0x 1.2x
OVLY Unlock Forecast - 30 Days FREE Trial $230M 9.6x 1.2x
PB Unlock Forecast - 30 Days FREE Trial $6074M 11.6x 0.8x
PCB Unlock Forecast - 30 Days FREE Trial $307M 9.7x 0.8x
PEBK Unlock Forecast - 30 Days FREE Trial $172M 10.1x 1.2x
PEBO Unlock Forecast - 30 Days FREE Trial $1046M 10.2x 0.9x
PFBX Unlock Forecast - 30 Days FREE Trial $93M 4.8x 1.0x
PKBK Unlock Forecast - 30 Days FREE Trial $260M 8.6x 0.8x
PMHG Unlock Forecast - 30 Days FREE Trial $175M 21.5x 2.0x
QCRH Unlock Forecast - 30 Days FREE Trial $1278M 11.1x 1.2x
QNBC Unlock Forecast - 30 Days FREE Trial $129M 10.1x 1.1x
RBB Unlock Forecast - 30 Days FREE Trial $343M 14.9x 0.7x
RBCAA Unlock Forecast - 30 Days FREE Trial $1343M 11.1x 1.3x
RMBI Unlock Forecast - 30 Days FREE Trial $139M 14.6x 1.1x
RNST Unlock Forecast - 30 Days FREE Trial $3324M 20.8x 0.9x
RRBI Unlock Forecast - 30 Days FREE Trial $452M 13.0x 1.4x
RVRF Unlock Forecast - 30 Days FREE Trial $270M 7.0x 1.1x
SBCF Unlock Forecast - 30 Days FREE Trial $2700M 19.5x 1.2x
SBFG Unlock Forecast - 30 Days FREE Trial $125M 12.9x 0.9x
SBSI Unlock Forecast - 30 Days FREE Trial $867M 9.8x 1.1x
SFBS Unlock Forecast - 30 Days FREE Trial $3874M 15.5x 2.3x
SFDL Unlock Forecast - 30 Days FREE Trial $98M 8.5x 0.5x
SLBK Unlock Forecast - 30 Days FREE Trial $99M 9.1x 1.0x
SPFI Unlock Forecast - 30 Days FREE Trial $600M 11.4x 1.3x
SRCE Unlock Forecast - 30 Days FREE Trial $1460M 10.1x 1.2x
SSB Unlock Forecast - 30 Days FREE Trial $9178M 15.4x 1.0x
STBA Unlock Forecast - 30 Days FREE Trial $1410M 14.2x 1.0x
STT Unlock Forecast - 30 Days FREE Trial $33419M 11.7x 1.2x
STT-PG Unlock Forecast - 30 Days FREE Trial $6554M 2.3x 0.2x
SYBT Unlock Forecast - 30 Days FREE Trial $1989M 15.3x 2.0x
TCBI Unlock Forecast - 30 Days FREE Trial $3981M 13.2x 1.1x
TCBIO Unlock Forecast - 30 Days FREE Trial $953M 7.1x 0.3x
TCBK Unlock Forecast - 30 Days FREE Trial $1424M 12.6x 1.1x
TECTP Unlock Forecast - 30 Days FREE Trial $73M 4.5x 0.6x
TFIN Unlock Forecast - 30 Days FREE Trial $1402M 142.2x 1.5x
THFF Unlock Forecast - 30 Days FREE Trial $657M 14.3x 1.1x
TMP Unlock Forecast - 30 Days FREE Trial $937M 11.9x 1.3x
TRST Unlock Forecast - 30 Days FREE Trial $721M 13.3x 1.0x
TYFG Unlock Forecast - 30 Days FREE Trial $111M x 0.7x
UBSI Unlock Forecast - 30 Days FREE Trial $5209M 13.2x 1.0x
UCB Unlock Forecast - 30 Days FREE Trial $3651M 13.3x 1.0x
UCB-PI Unlock Forecast - 30 Days FREE Trial $3035M 11.1x 0.8x
UNTY Unlock Forecast - 30 Days FREE Trial $475M 9.5x 1.5x
UVSP Unlock Forecast - 30 Days FREE Trial $863M 10.2x 0.9x
UWHR Unlock Forecast - 30 Days FREE Trial $73M 7.2x 1.3x
VBTX Unlock Forecast - 30 Days FREE Trial $3308M 28.6x 2.0x
WAL Unlock Forecast - 30 Days FREE Trial $8693M 10.2x 1.2x
WAL-PA Unlock Forecast - 30 Days FREE Trial $2343M 2.8x 0.3x
WASH Unlock Forecast - 30 Days FREE Trial $537M 13.8x 1.0x
WTBA Unlock Forecast - 30 Days FREE Trial $366M 11.0x 1.4x
WTFC Unlock Forecast - 30 Days FREE Trial $8896M 11.7x 1.2x
WTFCN Unlock Forecast - 30 Days FREE Trial $1780M 2.4x 0.3x

Frequently Asked Questions - FIRST BUSEY CORP /NV/ Stock Forecast

How accurate are FIRST BUSEY CORP /NV/ stock predictions?

Our AI model shows a 28% Spearman correlation coefficient for BUSE predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence FIRST BUSEY CORP /NV/ stock price forecasts?

Our analysis considers FIRST BUSEY CORP /NV/'s financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is FIRST BUSEY CORP /NV/ a good investment in 2025?

Based on our AI analysis, FIRST BUSEY CORP /NV/ shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are FIRST BUSEY CORP /NV/ forecasts updated?

FIRST BUSEY CORP /NV/ stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced FIRST BUSEY CORP /NV/ Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for FIRST BUSEY CORP /NV/ stock.

My Portfolio

Investment Dashboard

Loading your portfolio...